X @Bloomberg
Lilly wins the backing of EU regulators for its Alzheimer’s disease drug Kisunla in a specific group of patients https://t.co/x2fzm7e9j2 ...
Lilly wins the backing of EU regulators for its Alzheimer’s disease drug Kisunla in a specific group of patients https://t.co/x2fzm7e9j2 ...